In a groundbreaking leap toward combating heart disease, researchers at the University of Houston have unveiled an extraordinary technology that not only repairs damaged heart muscle cells in mice but propels them into regeneration post-heart attack, marking a paradigm shift in cardiac treatment.
Could this use of synthetic mRNA pave the way for a future where heart regeneration becomes an effective solution for humans facing the aftermath of a myocardial infarction?